Electrochemical assay of melanoma biomarker in human blood

xiaoying wang,hao li,xiaoxi li,yangyang chen,yongmei yin,genxi li
DOI: https://doi.org/10.1016/j.elecom.2013.12.003
IF: 5.443
2014-01-01
Electrochemistry Communications
Abstract:We report here an electrochemical assay to detect S100B, a serum biomarker of melanoma. This assay takes advantage of the 1:2 binding between S100B and its specific binding peptide. The first peptide immobilized on a gold electrode can capture S100B, while a second peptide modified with Gly–His–Lys copper ion chelating motif can generate signal. The chelated copper ion can also amplify the signal by catalyzing the oxidation of o-phenylenediamine (OPD) to electroactive 3-diaminophenazine (DAP). By using square wave voltammetry, a limit of detection as low as 0.1nM can be achieved. This method has also demonstrated favorable recovery in the complex serum sample, indicating potential clinical application in the future.
What problem does this paper attempt to address?